25 mg versus 50 mg dose of rectal diclofenac for prevention of post-ERCP pancreatitis in Japanese patients: a retrospective study

BMJ Open
Takeo YoshiharaKunio Suzuki

Abstract

The aim of the present study was to assess the appropriate administration dose of non-steroidal anti-inflammation drugs to prevent pancreatitis after endoscopic retrograde cholangiopancreatography (ERCP). Importantly, the 100 mg dose of diclofenac recommended in Western countries has not been permitted in Japan. A retrospective study. A single centre in Japan. This study enrolled patients who underwent ERCP at the Department of Gastroenterology, Osaka Saiseikai Senri Hospital, from April 2011 through June 2013, and who received either a 25 or a 50 mg dose of rectal diclofenac after ERCP. The occurrence of post-ERCP pancreatitis (PEP). A multivariate regression model was used to assess the effect of the 50 mg dose (the 50 mg group) of rectal diclofenac and to compare it to the occurrence of PEP referring to the 25 mg group. A total of 155 eligible patients received either 25 mg (84 patients) or 50 mg (71 patients) doses of rectal diclofenac after ERCP to prevent PEP. The proportion of PEP was significantly lower in the 50 mg group than in the 25 mg group (15.5% (11/71) vs 33.3% (28/84), p=0.018). In a multivariate analysis, the occurrence of PEP was significantly lower in the 50 mg group than in the 25 mg group even after adjust...Continue Reading

References

Sep 26, 1996·The New England Journal of Medicine·M L FreemanA M Pheley
Aug 1, 1997·Scandinavian Journal of Clinical and Laboratory Investigation·A MäkeläT Schröder
Sep 29, 2001·Gastrointestinal Endoscopy·M L FreemanJ P Roel
Apr 5, 2002·Endoscopy·T Rabenstein, E G Hahn
Mar 4, 2003·Gastrointestinal Endoscopy·Ali FazelJoseph E Geenen
May 10, 2005·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Alaa RostomLoren Laine
May 9, 2007·Gastroenterology·UNKNOWN American Gastroenterological Association (AGA) Institute on "Management of Acute Pancreatits" Clinical Practice and Economic, UNKNOWN AGA Institute Governing Board
Dec 17, 2009·Journal of Hepato-biliary-pancreatic Sciences·Shinju ArataMasao Tanaka
Mar 2, 2010·Gastrointestinal Endoscopy·Peter B CottonJohn J Vargo
May 28, 2010·Endoscopy·J-M DumonceauUNKNOWN European Society of Gastrointestinal Endoscopy
Apr 13, 2012·The New England Journal of Medicine·B Joseph ElmunzerUNKNOWN U.S. Cooperative for Outcomes Research in Endoscopy (USCORE)
Aug 15, 2012·Nephron. Clinical Practice·Arif Khwaja
Feb 5, 2013·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Ali AkbarMohammad Hassan Murad
Jul 31, 2013·The American Journal of Gastroenterology·Scott TennerUNKNOWN American College of Gastroenterology
Jan 13, 2015·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Nisa M KubiliunUNKNOWN United States Cooperative for Outcomes Research in Endoscopy (USCORE)
Mar 1, 2014·Endoscopy International Open·Lukejohn W DayMa Somsouk

❮ Previous
Next ❯

Software Mentioned

SPSS

Related Concepts

Related Feeds

Atrophic Gastritis

Atrophic Gastritis is a process where gastric glandular cells are lost and replaced with firbous tissues, as a result of chronic inflammation. Learn more about Atrophic Gastritis here.